Difference between revisions of "Fumarola C, et al. Biochem. Pharmacol. (2014) cited as Ref 361 in DOI: 10.1038/s41392-020-0110-5 (Q9624)"
Jump to navigation
Jump to search
(Created claim: title (P93): Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer, #quickstatements; #temporary_batch_1590010982689) |
(Created claim: Fourth Author string (P152): Alfieri RR, #quickstatements; #temporary_batch_1590155310798) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / Page(s) | |||
| + | 197-207 | ||
| Property / Page(s): 197-207 / rank | |||
| + | Normal rank | ||
| Property / Fourth Author string | |||
| + | Alfieri RR | ||
| Property / Fourth Author string: Alfieri RR / rank | |||
| + | Normal rank | ||
Latest revision as of 13:49, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Fumarola C, et al. Biochem. Pharmacol. (2014) cited as Ref 361 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Fumarola C
0 references
Bonelli MA
0 references
Petronini PG
0 references
2014
0 references
Biochem. Pharmacol.
0 references
90
0 references
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer (English)
0 references
197-207
0 references
Alfieri RR
0 references
